Published in Am J Clin Nutr on April 16, 2014
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study | NCT00342992
Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Int J Cancer (2014) 0.92
Vitamin D binding protein genotype is associated with plasma 25OHD concentration in West African children. Bone (2015) 0.85
Admixture mapping of serum vitamin D and parathyroid hormone concentrations in the African American-Diabetes Heart Study. Bone (2016) 0.76
Prostatic compensation of the vitamin D axis in African American men. JCI Insight (2017) 0.75
Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis. PLoS One (2015) 0.75
Common SNPs explain a large proportion of the heritability for human height. Nat Genet (2010) 35.02
A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet (2009) 30.09
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96
GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet (2010) 20.73
Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65
Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med (2013) 9.87
Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89
The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann Epidemiol (1994) 6.47
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet (2009) 5.62
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
Pathway analysis by adaptive combination of P-values. Genet Epidemiol (2009) 4.48
Genome-wide association study of circulating vitamin D levels. Hum Mol Genet (2010) 4.07
An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell (1999) 3.54
Vitamin D and calcium: a systematic review of health outcomes. Evid Rep Technol Assess (Full Rep) (2009) 3.51
Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta (2006) 2.97
Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab (1986) 2.81
Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet (1993) 2.27
Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int (2005) 2.23
Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3). Proc Natl Acad Sci U S A (2001) 1.94
A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations. J Steroid Biochem Mol Biol (2010) 1.92
New perspectives on the vitamin D binding protein. Cell Biochem Funct (2012) 1.88
Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family. J Clin Invest (1985) 1.83
Therapeutic potential of vitamin D-binding protein. Trends Biotechnol (2004) 1.55
Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin Chem (2001) 1.48
Human group-specific component (Gc) is a member of the albumin family. Proc Natl Acad Sci U S A (1985) 1.44
Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study. Cancer Res (2012) 1.24
Assessment of vitamin D status in male osteoporosis. Clin Chem (2005) 1.21
Association of vitamin D binding protein (VDBP) polymorphisms and serum 25(OH)D concentrations in a sample of young Canadian adults of different ancestry. J Steroid Biochem Mol Biol (2011) 1.11
Cellular uptake of steroid carrier proteins--mechanisms and implications. Mol Cell Endocrinol (2009) 1.07
Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer. Int J Cancer (2012) 1.06
Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer. Br J Cancer (2012) 1.02
Common variants of the vitamin D binding protein gene and adverse health outcomes. Crit Rev Clin Lab Sci (2013) 0.98
Population studies of Vitamin D Binding Protein microheterogeneity by mass spectrometry lead to characterization of its genotype-dependent O-glycosylation patterns. J Proteome Res (2008) 0.96
Isolation and characterization of the O-glycan chain of the human vitamin-D binding protein. Biochem Biophys Res Commun (1983) 0.92
Role of megalin and cubilin in the metabolism of vitamin D(3). Ther Apher Dial (2011) 0.90
Molecular cloning and functional expression of two members of mouse NeuAcalpha2,3Galbeta1,3GalNAc GalNAcalpha2,6-sialyltransferase family, ST6GalNAc III and IV. J Biol Chem (1999) 0.87
Molecular cloning and expression of human ST6GalNAc III: restricted tissue distribution and substrate specificity. J Biochem (2005) 0.86